OTCMKTS:ADOCY - ADOCIA/S Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ADOCIA/S Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $12.38 0.00 (0.00 %) (As of 01/2/2020) Add Compare Today's Range$12.38Now: $12.38▼$12.3850-Day Range$12.38MA: $12.38▼$12.3852-Week Range$11.57Now: $12.38▼$12.38Volume2 shsAverage VolumeN/AMarket Capitalization$85.67 millionP/E Ratio9.52Dividend YieldN/ABeta0.7 ProfileAnalyst RatingsAdvanced ChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform is designed and developed based on novel polymers, oligomers, and small molecules to enhance the effectiveness and/or safety of therapeutic proteins. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Tobacco products Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ADOCY Previous Symbol CUSIPN/A CIKN/A Webhttp://www.adocia.com/ Phone33-04-72-61-06-10Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio9.52 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$55.97 million Price / Sales1.53 Cash Flow$1.48 per share Price / Cash Flow8.38 Book Value$7.82 per share Price / Book1.58Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees132 Outstanding Shares6,920,000Market Cap$85.67 million Next Earnings Date3/9/2020 (Estimated) OptionableNot Optionable Receive ADOCY News and Ratings via Email Sign-up to receive the latest news and ratings for ADOCY and its competitors with MarketBeat's FREE daily newsletter. OTC:ADOCY Rates by TradingView ADOCIA/S (OTCMKTS:ADOCY) Frequently Asked Questions What is ADOCIA/S's stock symbol? ADOCIA/S trades on the OTCMKTS under the ticker symbol "ADOCY." When is ADOCIA/S's next earnings date? ADOCIA/S is scheduled to release their next quarterly earnings announcement on Monday, March 9th 2020. View Earnings Estimates for ADOCIA/S. What is the consensus analysts' recommendation for ADOCIA/S? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ADOCIA/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ADOCIA/S. Has ADOCIA/S been receiving favorable news coverage? News headlines about ADOCY stock have trended very negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ADOCIA/S earned a daily sentiment score of -4.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the near term. View News Stories for ADOCIA/S. Who are some of ADOCIA/S's key competitors? Some companies that are related to ADOCIA/S include LONZA GRP AG/ADR (LZAGY), Imperial Tobacco Group (IMBBY), H. Lundbeck A/S- (HLUYY), Pharming Group (PHGUF), Turning Point Brands (TPB), Standard Diversified Inc Class A (NYSEAMERICAN) (SDI), Healthier Choices Management (HCMC) and Gilla (GLLA). What other stocks do shareholders of ADOCIA/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other ADOCIA/S investors own include Relypsa (RLYP), Innate Pharma (IPHYF), Repros Therapeutics (RPRX), Spectrum Pharmaceuticals (SPPI), Verastem (VSTM), DBV TECHNOLOGIE/S (DBVT), Epizyme (EPZM), Exelixis (EXEL), Intercept Pharmaceuticals (ICPT) and MEI Pharma (MEIP). Who are ADOCIA/S's key executives? ADOCIA/S's management team includes the folowing people: Dr. Gérard Soula, Co-Founder, Chairman, CEO & Pres (Age 74)Mr. Olivier Soula, Co-Founder, Deputy CEO, VP, Director of R&D and Director (Age 49)Mr. Rémi Soula, Co-Founder, Director of Bus. Devel. & Intellectual Property and Scientific AdvisorMs. Valerie Danaguezian, CFO & Admin. DirectorMs. Geraldine Favre Soula, HR Devel. Director How do I buy shares of ADOCIA/S? Shares of ADOCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is ADOCIA/S's stock price today? One share of ADOCY stock can currently be purchased for approximately $12.38. How big of a company is ADOCIA/S? ADOCIA/S has a market capitalization of $85.67 million and generates $55.97 million in revenue each year. The company earns $8.99 million in net income (profit) each year or $1.30 on an earnings per share basis. ADOCIA/S employs 132 workers across the globe.View Additional Information About ADOCIA/S. What is ADOCIA/S's official website? The official website for ADOCIA/S is http://www.adocia.com/. How can I contact ADOCIA/S? ADOCIA/S's mailing address is 115 avenue Lacassagne, Lyon I0, 69003. The company can be reached via phone at 33-04-72-61-06-10 or via email at [email protected] MarketBeat Community Rating for ADOCIA/S (OTCMKTS ADOCY)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 96 (Vote Outperform)Underperform Votes: 120 (Vote Underperform)Total Votes: 216MarketBeat's community ratings are surveys of what our community members think about ADOCIA/S and other stocks. Vote "Outperform" if you believe ADOCY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ADOCY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/29/2020 by MarketBeat.com StaffFeatured Article: Balance Sheet
